Burney Company’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-167,351
Closed -$2.53M – 615
2024
Q1
$2.53M Buy
+167,351
New +$3.04M 0.1% 200
2022
Q2
– Sell
-3,186
Closed -$230K – 581
2022
Q1
$230K Buy
3,186
+85
+3% +$6.12K 0.01% 542
2021
Q4
$285K Hold
3,101
– – 0.01% 502
2021
Q3
$393K Sell
3,101
-13
-0.4% -$1.89K 0.02% 445
2021
Q2
$518K Hold
3,114
– – 0.02% 420
2021
Q1
$566K Buy
3,114
+8
+0.3% +$1.86K 0.03% 391
2020
Q4
$621K Buy
+3,106
New +$632K 0.03% 345

Other funds holding TDOC

Burney Company's TDOC Position: Q2 2024 in Review

Burney Company sold out of Teladoc Health (TDOC) in Q2 2024, closing a stake of 167,351 shares — an estimated $2.53M sold.

Burney Company first reported a position in TDOC in Q4 2020 and held it in 7 quarters. The position peaked at $2.53M in Q1 2024. 407 funds tracked by Wall St. Rank hold TDOC as of Q2 2024.

  • Burney Company reported no remaining Teladoc Health position as of Q2 2024 after selling out during the quarter.
  • Burney Company sold 167,351 Teladoc Health shares in Q2 2024, an estimated $2.53M.
  • Burney Company first reported a position in Teladoc Health in Q4 2020 and held it in 7 quarters.
  • Burney Company's Teladoc Health position peaked at $2.53M in Q1 2024.
  • 407 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2024.

Based on Burney Company's 13F filing for Q2 2024, filed 29 Jul 2024.